DD202293A5 - Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen - Google Patents

Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen Download PDF

Info

Publication number
DD202293A5
DD202293A5 DD81234080A DD23408081A DD202293A5 DD 202293 A5 DD202293 A5 DD 202293A5 DD 81234080 A DD81234080 A DD 81234080A DD 23408081 A DD23408081 A DD 23408081A DD 202293 A5 DD202293 A5 DD 202293A5
Authority
DD
German Democratic Republic
Prior art keywords
guanidino
formula
mmol
thiazole
compounds
Prior art date
Application number
DD81234080A
Other languages
German (de)
English (en)
Inventor
John L Lamattina
Christopher A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202293A5 publication Critical patent/DD202293A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
DD81234080A 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen DD202293A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19623180A 1980-10-14 1980-10-14
US06/293,574 US4374843A (en) 1980-10-14 1981-08-20 2-Guanidino-4-heteroarylthiazoles

Publications (1)

Publication Number Publication Date
DD202293A5 true DD202293A5 (de) 1983-09-07

Family

ID=26891753

Family Applications (4)

Application Number Title Priority Date Filing Date
DD81234080A DD202293A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DD81248820A DD207718A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DD81248822A DD207913A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DD81248821A DD207719A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen

Family Applications After (3)

Application Number Title Priority Date Filing Date
DD81248820A DD207718A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DD81248822A DD207913A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DD81248821A DD207719A5 (de) 1980-10-14 1981-10-14 Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen

Country Status (28)

Country Link
US (1) US4374843A (fi)
EP (1) EP0050458B1 (fi)
KR (1) KR850001858B1 (fi)
AR (3) AR228674A1 (fi)
AT (1) ATE11048T1 (fi)
AU (2) AU530589B2 (fi)
CA (1) CA1156239A (fi)
CS (1) CS231182B2 (fi)
DD (4) DD202293A5 (fi)
DE (1) DE3168067D1 (fi)
DK (1) DK453181A (fi)
ES (4) ES506216A0 (fi)
FI (1) FI75821C (fi)
GR (1) GR75098B (fi)
HK (1) HK52387A (fi)
HU (2) HU186788B (fi)
IE (1) IE51642B1 (fi)
IL (1) IL64035A (fi)
KE (1) KE3707A (fi)
MY (1) MY8700512A (fi)
NO (1) NO159654C (fi)
NZ (1) NZ198629A (fi)
PH (3) PH17562A (fi)
PL (3) PL134491B1 (fi)
PT (1) PT73817B (fi)
SG (1) SG23487G (fi)
SU (1) SU1153829A3 (fi)
YU (4) YU42434B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482723A (en) * 1983-04-11 1984-11-13 Pfizer Inc. Process for preparation of 4-acetyl-2-substituted-imidazoles
US4435396A (en) 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
AU542287B2 (en) * 1982-06-17 1985-02-14 Toyama Chemical Co. Ltd. Process for producing 2-(2-aminothiazol-4-yl) glyoxylic acid derivative, it:s salt and intermediates therefor
EP0156644A1 (en) * 1984-04-02 1985-10-02 Pfizer Inc. Process and intermediates for 4-acetylimidazoles
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4591595A (en) * 1984-10-11 1986-05-27 Pfizer Inc. 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
ES2031514T3 (es) * 1986-08-29 1992-12-16 Pfizer Inc. 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
DE3750023T2 (de) * 1986-10-29 1994-09-29 Pfizer Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
EP0575614A1 (en) * 1991-03-13 1993-12-29 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
KR20080039979A (ko) * 2005-08-23 2008-05-07 우베 고산 가부시키가이샤 1-치환-5-아실이미다졸 화합물의 제법
JPWO2013146754A1 (ja) 2012-03-27 2015-12-14 塩野義製薬株式会社 Ｔｒｐｖ４阻害活性を有する芳香族複素５員環誘導体
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516777A (fr) * 1966-08-02 1968-02-05 Innothera Lab Sa Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation
US3519637A (en) * 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
HU168776B (fi) * 1973-11-09 1976-07-28
DE2614189A1 (de) * 1976-04-02 1977-10-20 Hoechst Ag Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives

Also Published As

Publication number Publication date
CS750081A2 (en) 1984-02-13
YU105383A (en) 1983-10-31
PL241643A1 (en) 1983-11-21
KE3707A (en) 1987-04-03
AR229703A1 (es) 1983-10-31
YU42078B (en) 1988-04-30
ATE11048T1 (de) 1985-01-15
YU42076B (en) 1988-04-30
YU42077B (en) 1988-04-30
EP0050458B1 (en) 1985-01-02
ES515157A0 (es) 1983-06-01
PL133712B1 (en) 1985-06-29
YU105183A (en) 1983-10-31
ES8301978A1 (es) 1982-12-16
IE51642B1 (en) 1987-01-21
EP0050458A2 (en) 1982-04-28
FI75821C (fi) 1988-08-08
DD207913A5 (de) 1984-03-21
NO159654B (no) 1988-10-17
SG23487G (en) 1987-07-10
ES8306750A1 (es) 1983-06-01
ES8306751A1 (es) 1983-06-01
YU105283A (en) 1983-10-31
PL241644A1 (en) 1983-11-21
AU7628781A (en) 1982-04-22
ES506216A0 (es) 1982-12-16
FI75821B (fi) 1988-04-29
ES515158A0 (es) 1983-06-01
MY8700512A (en) 1987-12-31
AU548992B2 (en) 1986-01-09
ES515159A0 (es) 1983-06-01
HK52387A (en) 1987-07-17
IE812384L (en) 1982-04-14
AR228675A1 (es) 1983-03-30
HU186788B (en) 1985-09-30
FI813177L (fi) 1982-04-15
YU42434B (en) 1988-08-31
NZ198629A (en) 1985-02-28
SU1153829A3 (ru) 1985-04-30
NO159654C (no) 1989-01-25
EP0050458A3 (en) 1982-09-01
DD207718A5 (de) 1984-03-14
PH17562A (en) 1984-10-01
DE3168067D1 (en) 1985-02-14
YU246481A (en) 1983-10-31
IL64035A0 (en) 1982-01-31
PT73817B (en) 1983-11-07
PL134491B1 (en) 1985-08-31
ES8306749A1 (es) 1983-06-01
PT73817A (en) 1981-11-01
US4374843A (en) 1983-02-22
AR228674A1 (es) 1983-03-30
DD207719A5 (de) 1984-03-14
PL233430A1 (en) 1983-11-21
PH17856A (en) 1985-01-09
CS231182B2 (en) 1984-10-15
DK453181A (da) 1982-04-15
KR830007638A (ko) 1983-11-04
AU530589B2 (en) 1983-07-21
AU3206284A (en) 1984-11-29
IL64035A (en) 1986-01-31
NO813442L (no) 1982-04-15
GR75098B (fi) 1984-07-13
HU191895B (en) 1987-04-28
PL135331B1 (en) 1985-10-31
CA1156239A (en) 1983-11-01
KR850001858B1 (ko) 1985-12-28
PH18467A (en) 1985-07-18

Similar Documents

Publication Publication Date Title
DE3218584C2 (fi)
DD202293A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DD261787A5 (de) Antiarrhythmisch wirksame phenylpiperazin-mittel
DD233374A5 (de) Verfahren zur herstellung von 2-(n-subst.-guanidino)-4-heteroarylthiazole
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
CH652395A5 (de) 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen.
DD216929A5 (de) Verfahren zur herstellung von thiazolidinderivaten
DE2928842A1 (de) Pyrimidonderivate
DE19824175A1 (de) Amino-azol-Verbindungen
DE2847792C2 (fi)
CH674206A5 (fi)
DD265403A5 (de) Verfahren zum herstellen herzstimulierender chinolene
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DD209828A5 (de) Verfahren zur herstellung von 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazolen
DE3728491A1 (de) Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
DE3618724C2 (de) N-[3-(Nitro)-chinol-4-yl]-carboxamidinamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2550959C3 (de) Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3336409A1 (de) Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2457309A1 (de) 2-phenylhydrazinothiazolin- beziehungsweise 2-phenylhydrazinothiazininderivate sowie ihre verwendung und verfahren zur herstellung derselben
DE2832309C2 (fi)
DE3044566A1 (de) N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
AT375656B (de) Verfahren zur herstellung von neuen 3-amino-5(4-pyridyl)-1,2,4-triazol-basen und ihren salzen
DE3413875A1 (de) Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
DE2403416C2 (de) 1-Phenylimidazol-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee